Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease ; volume:12 ; number:1 ; day:23 ; month:9 ; year:2020 ; pages:1-11 ; date:12.2020
Alzheimer's research & therapy ; 12, Heft 1 (23.9.2020), 1-11, 12.2020
- Urheber
-
Cho, Hanna
Baek, Min Seok
Lee, Hye Sun
Lee, Jae Hoon
Ryu, Young Hoon
Lyoo, Chul Hyoung
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-020-00685-4
- URN
-
urn:nbn:de:101:1-2020111122003996649398
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cho, Hanna
- Baek, Min Seok
- Lee, Hye Sun
- Lee, Jae Hoon
- Ryu, Young Hoon
- Lyoo, Chul Hyoung
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer’s disease
Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease
Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
Combining connectivity, related pathologies, and genetic factors to explain tau accumulation in Alzheimer’s disease
Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer’s disease
Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease
Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer’s disease
Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease
Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
Combining connectivity, related pathologies, and genetic factors to explain tau accumulation in Alzheimer’s disease
Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer’s disease
Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease
Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer’s disease
Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease
Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
Combining connectivity, related pathologies, and genetic factors to explain tau accumulation in Alzheimer’s disease
Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer’s disease
Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease